Unibest 优贝德
← Back to patent-cliff list

CAS 107-21-1

1,2-Dihydroxyethaneethane-1,2-diol

Codes(IV)409139-6-a、CRISA-006、MACI-010

Application context (from source-drug indications)

转甲状腺素运载蛋白淀粉样变性氯苯唑酸心脏病氯苯唑酸特应性皮炎克立硼罗皮炎克立硼罗湿疹克立硼罗斑秃克立硼罗局部硬皮病克立硼罗斑块银屑病克立硼罗肺动脉高压马昔腾坦肺性高血压马昔腾坦慢性病马昔腾坦慢性血栓栓塞性肺高压马昔腾坦血栓栓塞马昔腾坦心绞痛马昔腾坦

Source drugs (routes using this intermediate)

DrugTierExpiry
氯苯唑酸TafamidisTier C — Watch / trade-
克立硼罗CrisaboroleTier C — Watch / trade-
马昔腾坦MacitentanTier B — Position early-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualifications
Unibest Taizhou GMP-like Site2-BROMO-5-HYDROXYBENZALDEHYDE
Pharmaceutical Intermediates
询价询价询价
Qualified Partner — East China API Works4-(4-Bromo-3-formyl-phenoxy)-benzonitrile
Pharmaceutical Intermediates
询价询价询价
Unibest Nantong cGMP Site4-[4-bromo-3-(hydroxymethyl)phenoxy]benzonitrile
Pharmaceutical Intermediates
询价询价询价
Unibest Taizhou GMP-like Site[2-bromo-5-(4-cyanophenoxy)phenyl]methyl acetate
Pharmaceutical Intermediates
询价询价询价

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.